Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

Table 5

Comparison of the main outcomes in the COVID-19 patients according to alleles.

	Alleles
	DD	DI	II
Time to defervescence (days)	3 [1-27]	3 [1-29]	3 [5-10]	0.09
Duration of hospitalisation (days)	9 [4-77]	8 [1-46]	10 [5-10]	0.91
Mortality	1 (2.2%)	4 (6.8%)	—	0.43

Brackets indicate minimum and maximum ranges.